{
    "id": "NGN-SA-M500-108-1771349174990",
    "questionType": "multipleChoice",
    "caseId": "Case-500-108",
    "clientData": [
        {
            "type": "nursesNotes",
            "time": "1000",
            "note": "Client is a 55-year-old male with a history of Crohn's disease, admitted for scheduled infliximab infusion. Last dose was over one year ago. Client states, 'I missed my last few doses because my insurance changed and the co-pay was too high.' Pre-medications administered without issue. Infliximab infusion 5 mg/kg in 250 mL NS initiated via peripheral IV at 100 mL/hr. Client is alert and oriented, watching television."
        },
        {
            "type": "nursesNotes",
            "time": "1015",
            "note": "Client used call light. Reports feeling 'itchy all over' and a 'lump in my throat.' Voice sounds hoarse. Visible flushing noted on face and chest. Widespread urticaria observed on torso. Client appears anxious and is breathing rapidly."
        },
        {
            "type": "vitals",
            "data": [
                {
                    "time": "0945 (Pre-infusion)",
                    "BP": "128/78 mmHg",
                    "HR": "82 bpm",
                    "RR": "16/min",
                    "SpO2": "98% on room air",
                    "Temp": "37.0째C (98.6째F)"
                },
                {
                    "time": "1015 (Current)",
                    "BP": "90/50 mmHg",
                    "HR": "135 bpm",
                    "RR": "28/min",
                    "SpO2": "89% on room air",
                    "Temp": "37.2째C (99.0째F)"
                }
            ]
        },
        {
            "type": "labs",
            "data": [
                {
                    "name": "Troponin I",
                    "value": "0.08 ng/mL",
                    "reference": "< 0.04 ng/mL"
                },
                {
                    "name": "Lactate, venous",
                    "value": "3.5 mmol/L",
                    "reference": "0.5-2.2 mmol/L"
                },
                {
                    "name": "Potassium",
                    "value": "4.1 mEq/L",
                    "reference": "3.5-5.0 mEq/L"
                },
                {
                    "name": "BUN",
                    "value": "22 mg/dL",
                    "reference": "7-20 mg/dL"
                },
                {
                    "name": "Creatinine",
                    "value": "1.1 mg/dL",
                    "reference": "0.6-1.2 mg/dL"
                }
            ]
        },
        {
            "type": "meds",
            "data": [
                {
                    "name": "Infliximab 5 mg/kg IV infusion",
                    "status": "Infusing"
                },
                {
                    "name": "Metoprolol 25 mg PO",
                    "status": "Scheduled, due now"
                },
                {
                    "name": "Epinephrine (1 mg/mL) 0.3 mg IM",
                    "status": "Available PRN for anaphylaxis"
                },
                {
                    "name": "Diphenhydramine 50 mg IV Push",
                    "status": "Available PRN for allergic reaction"
                }
            ]
        }
    ],
    "question": "The nurse has just assessed the client at 1015. Which action should the nurse take immediately?",
    "options": {
        "A": "Administer the scheduled dose of metoprolol.",
        "B": "Request a stat 12-lead ECG.",
        "C": "Stop the infliximab infusion.",
        "D": "Administer diphenhydramine 50 mg IV push."
    },
    "correctAnswer": "C",
    "answerBreakdown": {
        "A": {
            "isCorrect": false,
            "rationale": "This action is contraindicated and extremely dangerous. The client is experiencing anaphylactic shock with profound hypotension. Metoprolol, a beta-blocker, will worsen hypotension and can block the life-saving effects of epinephrine on beta-adrenergic receptors, which is the primary treatment for anaphylaxis. This is a critical 'DON'T PROCEED' medication."
        },
        "B": {
            "isCorrect": false,
            "rationale": "While the client is tachycardic and has a mildly elevated troponin (suggesting demand ischemia from shock), the root cause is anaphylaxis, not a primary cardiac event. Obtaining an ECG is a secondary action that must not delay immediate life-saving interventions. The priority is to treat the shock."
        },
        "C": {
            "isCorrect": true,
            "rationale": "This is the absolute first priority. The client is exhibiting classic signs of a severe infusion reaction/anaphylaxis (hypotension, tachycardia, hypoxia, urticaria, angioedema). Stopping the causative agent is the most critical and immediate step to prevent further administration of the antigen and worsening of the life-threatening reaction."
        },
        "D": {
            "isCorrect": false,
            "rationale": "While diphenhydramine is used to treat anaphylaxis, it is a second-line medication that primarily addresses histamine-mediated symptoms like itching and hives. It does not treat the life-threatening airway compromise or hypotension. The priority is to first stop the trigger, then administer epinephrine, and then consider adjunctive therapies like antihistamines."
        }
    }
}